Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.6460
-0.0480 (-6.92%)
Jan 21, 2026, 5:19 PM CET
Nanologica AB Company Description
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.
It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces.
The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity.
Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
Nanologica AB (publ)
| Country | Sweden |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 19 |
| CEO | Andreas Bhagwani |
Contact Details
Address: Forskargatan 20 G Södertälje, 151 36 Sweden | |
| Phone | 46 8 41 07 49 49 |
| Website | nanologica.com |
Stock Details
| Ticker Symbol | NICA |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0005454873 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Andreas Bhagwani | Chief Executive Officer |
| Eva Osterman | Chief Financial Officer |
| Åsa Bergström | Chief Operating Officer |
| Johanna Johansson | Director of IR, Communications and Marketing |
| Katarina Alenas | Senior Vice President of Chromatography |